Published 2017
| Version v1
Publication
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study
- Creators
- Bogani, Giorgio
- Matteucci, Laura
- Tamberi, Stefano
- Arcangeli, Valentina
- Ditto, Antonino
- Maltese, Giuseppa
- Signorelli, Mauro
- Martinelli, Fabio
- Chiappa, Valentina
- Leone Roberti Maggiore, Umberto
- Perotto, Stefania
- Scaffa, Cono
- Comerci, Giuseppe
- Stefanetti, Marco
- Raspagliesi, Francesco
- Lorusso, Domenica
- Others:
- Bogani, Giorgio
- Matteucci, Laura
- Tamberi, Stefano
- Arcangeli, Valentina
- Ditto, Antonino
- Maltese, Giuseppa
- Signorelli, Mauro
- Martinelli, Fabio
- Chiappa, Valentina
- Leone Roberti Maggiore, Umberto
- Perotto, Stefania
- Scaffa, Cono
- Comerci, Giuseppe
- Stefanetti, Marco
- Raspagliesi, Francesco
- Lorusso, Domenica
Description
Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) may be a valuable treatment option in advanced ovarian cancer when primary cytoreduction is not feasible. However, a consensus on the ideal number of NACT cycles is still lacking. In the present investigation, we aimed to evaluate how number of cycles of NACT influenced patients' outcomes.
Additional details
- URL
- http://hdl.handle.net/11567/883041
- URN
- urn:oai:iris.unige.it:11567/883041
- Origin repository
- UNIGE